Exercise Rehabilitation for Peripheral Neuropathy
(EX-CIPN Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to learn if the EX-CIPN exercise-based intervention is feasible, acceptable, and safe in participants with persistent chemotherapy-induced peripheral neuropathy (CIPN). It will also give insight on the effectiveness of the exercise intervention in treating CIPN symptoms. The main questions it aims to answer are: * Is EX-CIPN safe, acceptable, and feasible in cancer survivors experiencing persistent CIPN? * Are the study design and methods feasible (recruitment and retention rates, feasibility of data collection and procedures)? Researchers will provide all participants with the exercise-based intervention. Participants will: * Complete assessments at baseline, immediately post-intervention, and 3-months post-intervention * Complete a 10-week remote, individualized exercise program * Receive health coaching calls on weeks 2, 3, 4, 6, and 8 of the intervention * Wear a FitBit throughout the study to track physical activity and promote behaviour change
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently taking ado-trastuzumab emtansine (TDM1).
What data supports the effectiveness of the treatment EX-CIPN for peripheral neuropathy?
Research shows that exercise therapy can improve symptoms and physical function in people with diabetic neuropathy, and specific exercise regimens can enhance balance and confidence in those with peripheral neuropathy. Additionally, tai chi, a form of exercise, has been found to increase strength, balance, and stamina in older adults with peripheral neuropathy.12345
Is exercise rehabilitation safe for people with peripheral neuropathy?
How is the EX-CIPN treatment different from other treatments for peripheral neuropathy?
EX-CIPN is unique because it focuses on exercise-based rehabilitation to manage peripheral neuropathy, which is different from traditional drug treatments. It aims to improve strength, stamina, and sensation through physical activity, offering a non-drug approach to reduce symptoms and enhance quality of life.124611
Eligibility Criteria
This trial is for cancer survivors who are dealing with persistent chemotherapy-induced peripheral neuropathy (CIPN). Participants should be willing to engage in a 10-week exercise program, receive health coaching calls, and wear a FitBit. Specific eligibility criteria were not provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants complete a 10-week remote, individualized exercise program with health coaching calls and Fitbit monitoring
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at baseline, immediately post-intervention, and 3-months post-intervention
Treatment Details
Interventions
- EX-CIPN
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor